EUROPEAN Device Guide / Stents

Coronary Balloon-Expandable Drug-Eluting Stents

23 products

Company Name	Product Name	Drug Delivered	Material Used	Polymer Type	Maximum Guidewire Size (inch)	Introducer Size (F)	Stent Diameter (mm)	Stent Length (mm)	Delivery System Length (cm)	CE Mark Indications
Concept Medical	Abluminus DES+	Sirolimus	Cobalt chromium alloy L605	Customized biodegradable polymer matrix	0.014	5	2.25, 2.50, 2.75, 3, 3.50, 4, 4.50, 5	8, 12, 16, 20, 24, 28, 32, 36, 40,44, 48, 52	RX 140	Indicated for DM and AMI
Concept Medical	Abluminus NP	Sirolimus	Cobalt chromium alloy L605	Polymer free	0.014	5	2.25, 2.50, 2.75, 3, 3.50, 4	8, 12, 16, 20, 24, 28, 32, 36, 40	140	Indicated for improving luminal diameter in patients, including those with bleeding risks or those who have to undergo DAPT interruption in the near future for any surgery and who have associated risks, such as diabetes mellitus, symptomatic coronary artery disease, stable angina, unstable angina, or documented silent ischemia due to atherosclerotic lesions in native coronary arteries with a reference vessel diameter 2.25 to 4 mm and lesion length of ≤ 36 mm
Rontis AG	Abrax	Sirolimus	Carbonized stainless steel alloy	Biodegradable PLGA	0.014	Guide catheter: 5 (minimum)	2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 4	10, 14, 18, 24, 28, 34, 38	142	Coronary
Balton	Alex Plus	Sirolimus	Cobalt chromium	PLGA	0.014	5	2, 2.25, 2.5, 2.75, 3, 3, 3.5, 3.75, 4, 4.5	8, 10, 12, 15, 18, 22, 25, 29, 34, 36, 38, 40	140	–
iVascular	Angiolite	Sirolimus	Cobalt chromium (CoCr L605)	Biostable fluorinated acrylate	0.014	5	2, 2.25, 2.5, 2.75, 3, 3.5, 4, 4.5	9, 14, 16, 19, 24, 29, 34, 39, 44, 49	142	Indicated for increasing the internal diameter of an artery with the aim of improving blood flow in the following cases: (1) patients with symptomatic ischemic heart disease due to de novo stenotic and restenotic lesions; (2) patients with occlusive disease due to acute myocardial infarction
Meril Life Sciences Pvt. Ltd.	BioMime - Sirolimus Eluting Coronary Stent System	Sirolimus	Cobalt chromium L605	Biodegradable and biocompatible	0.014	5	2, 2.25, 2.5, 2.75, 3, 3.5, 4, 4.5	8, 13, 16, 19, 24, 29, 32, 37, 40, 44, 48	140–142	–
Meril Life Sciences Pvt. Ltd.	BioMime Morph - Sirolimus Eluting Coronary Stent System	Sirolimus	Cobalt chromium L605	Biodegradable and biocompatible	0.014	5	2.75–2.25, 3–2.5, 3.5–3	30, 40, 50, 60	142	–
Balton	Bioss Lim C	Sirolimus	Cobalt chromium	PLGA	0.014	5	2.5/3; 2.5/3.25; 2.75/3.5; 3/3.5; 3/3.75; 3.5/4.25; 3.75/4.5	16, 19, 24	140	Bifurcation-optimized stent for coronary vessels with one profiled balloon
Alvimedica	Coracto	Sirolimus	316 LVM stainless steel	PLGA	0.014	5 (GC compatibility)	2.5, 2.75, 3, 3.5, 4	9, 13, 17, 21, 24, 28, 32	150	–
B. Braun Melsungen AG	Coroflex ISAR NEO	Sirolimus	Cobalt chromium alloy L605	–	0.014	5 (standard guiding catheter), 6 (kissing compatibility)	2, 2.25, 2.5, 2.75, 3, 3.5, 4	9, 12, 16, 19, 24, 28, 32, 38	145	–
Alvimedica	Cre8	Amphilimus formulation: sirolimus + fatty acid	L605 cobalt chromium alloy integrally coated by bio inducer surface	–	0.014	5 (GC compatibility)	2.25, 2.5, 2.75, 3, 3.5, 4, 4.5	8, 12, 16, 20, 25, 31, 38, 46	142	–
Alvimedica	Cre8 EVO	Amphilimus formulation: sirolimus + fatty acid	L605 cobalt chromium alloy integrally coated by bio inducer surface	–	0.014	5 (GC compatibility)	2, 2.25, 2.5, 2.75, 3, 3.5, 4, 4.5	9, 13, 16, 20, 26, 33, 40, 46	142	–
Meril Life Sciences Pvt. Ltd.	Metafor - Sirolimus Eluting Coronary Stent System	Sirolimus	Cobalt chromium L605	Biodegradable and biocompatible	0.014	5	2, 2.25, 2.5, 2.75, 3, 3.5, 4, 4.5	8, 13, 16, 19, 24, 29, 32, 37, 40, 44, 48	140–142	–
Medtronic	Onyx Frontier Zotarolimus-Eluting Stent System	Zotarolimus	Shell: cobalt alloy, core: platinum iridium	Biolinx	0.014	Minimum guide catheter size: 5	2, 2.25, 2.75, 3, 3.5, 4, 4.5, 5	8, 12, 15, 18, 22, 26, 30, 34, 38 (2 mm not available in 34, 38 mm lengths; 4.5, 5 mm not available in 8, 34, 38 mm lengths)	140	1-month DAPT in high-bleeding risk patients including those unable to tolerate long term DAPT; CTO; bifurcations; left main; diabetes; multivessel disease; acute coronary syndrome; acute myocardial infarction; unstable angina; ISR; total occlusions; small vessel
Balton	Prolim	Sirolimus	Stainless steel	PLGA	0.014	5	2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.5, 5	8, 10, 12, 15, 18, 22, 25, 29, 34, 36, 38, 40	140	–
Boston Scientific Corporation	Promus Elite Everolimus-Eluting Platinum Chromium Coronary Stent System	Everolimus	Platinum chromium	PVDF-HFP (poly-vinylidene fluoride-hexafluoropropylene)	0.014	Minimum guide catheter size: 5 (≥ 1.42 mm)	2.25, 2.5, 2.75, 3, 3.5, 4	8, 12, 16, 20, 24, 28, 32, 38	144	–
Boston Scientific Corporation	Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System	Everolimus	Platinum chromium	PVDF-HFP (poly-vinylidene fluoride-hexafluoropropylene)	0.014	Minimum guide catheter size: 5 (MR: ≥ 1.42 mm)	2.25, 2.5, 2.75, 3, 3.5, 4	8, 12, 16, 20, 24, 28, 32, 38	MR: 144	–
Medtronic	Resolute Integrity Zotarolimus-Eluting Stent System	Zotarolimus	Cobalt alloy	BioLinx	0.014	Minimum guide catheter size: 5 (RX and OTW: ≥ 0.056 inch/1.42 mm)	2.25, 2.5, 2.75, 3, 3.5, 4	8, 9, 12, 14, 15, 18, 22, 23, 26, 30, 34, 38	RX: 140; OTW: 135	Coronary
Medtronic	Resolute Onyx Zotarolimus-Eluting Stent System	Zotarolimus	Shell: cobalt alloy, core: platinum iridium	BioLinx	0.014	Minimum guide catheter size: 5	2, 2.25, 2.5, 2.75, 3, 3.5, 4, 4.5, 5	8, 12, 15, 18, 22, 26, 30, 34, 38 (2 mm not available in 34, 38 mm lengths; 4.5, 5 mm not available in 8, 34, 38 mm lengths)	140	1-month DAPT in high-bleeding risk patients including those unable to tolerate long term DAPT; CTO; bifurcations; left main; diabetes; multivessel disease; acute coronary syndrome; acute myocardial infarction; unstable angina; ISR; total occlusions; small vessel
Abbott	Xience Alpine Everolimus-Eluting Coronary Stent System	Everolimus	Cobalt chromium	Fluoropolymer	0.014	Minimum guide catheter size: 5 (RX and OTW): (≥ 0.056 inch/1.42 mm); 4-mm diameter: 6 (≥ 1.68 mm)	2.25, 2.5, 2.75, 3, 3.25, 3.5, 4	8, 12, 15, 18, 23, 28, 33, 38	145	–
Abbott	Xience Sierra Everolimus-Eluting Coronary Stent System	Everolimus	Cobalt chromium	Fluoropolymer	0.014	Minimum guide catheter size: 5 (RX and OTW: ≥ 0.056 inch/1.42 mm); 4-mm diameter: 6 (≥ 1.68 mm)	2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 4	8, 12, 15, 18, 23, 28, 33, 38	145	Coronary
Abbott	Xience Skypoint RX Everolimus-Eluting Coronary Stent System	Everolimus	Cobalt chromium	Fluoropolymer	0.014	Minimum guide catheter size: 5 F/0.056/1.42 mm (2.25–4 mm, 8–38 mm); 6 F/0.070/1.78 mm (2.5–4 mm, 48 mm); 6 F/0.070/1.78 mm (4.5–5 mm, 12–33 mm)	2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 4, 4.5, 5	8, 12, 15, 18, 23, 28, 33, 38, 48	145	Indicated for improving coronary artery luminal diameter in the following: (1) patients with symptomatic ischemic heart disease due to discrete de novo native coronary artery lesions; (2) for restoring coronary flow in patients experiencing acute myocardial infarction who present within 12 hours of symptom onset; (3) for the treatment of patients with concomitant diabetes, acute coronary syndrome, dual vessel lesions (two lesions in two different epicardial vessels), lesions residing within small coronary vessels; lesions where treatment results in the jailing of side branches (lesions with a side branch < 2 mm in diameter or an ostial stenosis < 50%); for the treatment of elderly patients (age ≥ 65) and for treatment of both men and women; (4) for treatment of patients with high bleeding risk (HBR) under dual anti-platelet therapy (DAPT) as short as 28 days; (5) for the treatment of patients presenting with in-stent restenosis in coronary artery lesions; chronic total occluded coronary artery lesions (defined as coronary artery lesions with TIMI flow 0 and lasting longer than 3 months); coronary artery bifurcation lesions and left main coronary artery lesions; in all cases, the treated lesion length should be less than the nominal stent length (8, 12, 15, 18, 23, 28, 33, or 38 mm) with a reference vessel diameter of ≥ 2 mm and ≤ 5.25 mm
Cardionovum GmbH	Xlimus	Sirolimus drug elution	Cobalt chromium alloy L-605	Biodegradable PLA	0.014	5–6	2.25, 2.5, 2.75, 3, 3.5, 4, 4.5, 5	8, 12, 16, 20, 24, 28, 32, 36, 40	140	Symptomatic ischemic heart disease deriving from de novo lesions in native coronary arteries; acute myocardial infarction for restoring coronary blood flow; concomitant conditions: diabetes, acute coronary syndrome, lesions in two vessels, and smaller coronary arteries

We value keeping the Device Guide up to date.

If you want to add or update your company’s device listings, please let us know!

Stents

Bioabsorbable Polymer Drug-Eluting Stents

10 products

Bioresorbable Scaffolds

3 products

Coronary Balloon-Expandable Drug-Eluting Stents

23 products

Coronary Balloon-Expandable Stents

12 products

Covered Stents

2 products

Ostial Stent Positioning Systems

1 product

More Categories:

Balloons Catheters Sheaths Stents Structural Heart Valves Wires Other Devices View All

EUROPEAN Device Guide / Stents

Coronary Balloon-Expandable Drug-Eluting Stents

Stents

Latest News

Most Read Articles